Trial Profile
Phase III trial of Travivo in patients with major depressive disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Mar 2016
Price :
$35
*
At a glance
- Drugs Gepirone (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors Fabre-Kramer Pharmaceuticals
- 22 Mar 2016 New trial record
- 17 Mar 2016 According to Fabre-Kramer Pharmaceuticals media release, the Food and Drug Administration (FDA) Office of New Drugs (OND) granted its appeal pursuant to the agency's Formal Dispute Resolution (FDR) process.